< Back

Grand Rounds | BCH Oakland Research Update 2020: CAR-T Cell Therapy, Coronavirus Vaccine and Screening for Trauma & Adversity


Tuesday, December 8, 2020 8:00 AM - 9:00 AM


Presented by:
UCSF Benioff Children’s Hospital Oakland

Anu Agrawal, MD
Associate Professor, Department of Pediatrics
Division of Hematology/Oncology/BMT

Peter Beernink, PhD
Associate Professor, Pediatrics
UCSF School of Medicine

Dayna Long, MD
Medical Director
Department of Community Health and Engagement

Kelley Meade, MD
Associate Dean, Clinical and Academic Affairs (Moderator)

  1. Describe the process to treat patients with CAR-T cells. (Agrawal)
  2. Identify obstacles to treat patients with CAR-T cells. (Agrawal)
  3. Explain different COVID-19 vaccine approaches. (Beernink)
  4. Differentiate between advantages and disadvantages of different vaccine platforms. (Beernink)
  5. Identify algorithm to screen for adversity, trauma and determinants of health. (Long)
  6. Examine ways in which screening results can be used to tailor treatment planning and follow-up. (Long)

UCSF Benioff Children’s Hospital Oakland is accredited by the California Medical Association to provide continuing medical education for physicians.
UCSF Benioff Children’s Hospital Oakland designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Zoom Participants:
For CME credit, evaluations must be completed by 6pm the day after Grand Rounds. Please email before 12PM on 12/8/2020 for the CME-required evaluation link AND webinar log in information for this lecture.

Did you miss Grand Rounds? Visit and use password CHRCO to view recorded Grand Rounds presentations.


This record has been viewed 42 times.


Be the first to leave a comment.

Post your comment and join the discussion.

CAPTCHA Validation